At 307.6x earnings with negative EPS of -19.8 and no forward P/E guidance, this is not a growth stock being misunderstood — it is a structurally unprofitable company the market is valuing on hope rather than cash generation. The absence of a forward P/E and PEG removes any credible growth anchor, while an Altman Z-Score of 2.1 places it in the grey zone, signaling moderate balance sheet risk rather than distress immunity. A Piotroski F-Score of 2 confirms weak fundamental momentum, and a -0.70% ROIC combined with a -1.00% operating margin shows capital is not being deployed productively. At a $364M market cap with a 1.2x price-to-sales and 1.1x price-to-book, the stock looks optically cheap on assets but fundamentally impaired on earnings power.